Ignite Creation Date:
2025-12-25 @ 3:33 AM
Ignite Modification Date:
2025-12-26 @ 2:15 AM
Study NCT ID:
NCT03174405
Status:
COMPLETED
Last Update Posted:
2022-09-29
First Post:
2017-05-31
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Avelumab and Cetuximab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer - The Phase II AVETUX-CRC Trial.
Sponsor:
AIO-Studien-gGmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-17
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-16
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-31
First Submit QC Date:
None
Study First Post Date:
2017-06-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-28
Last Update Post Date:
2022-09-29
Last Update Post Date Type:
ACTUAL